Axxia Pharmaceuticals
Bel Air
About Axxia Pharmaceuticals
Axxia Pharmaceuticals, Inc., a specialty pharmaceutical company, provides implantable polymeric drug delivery technologies. Its solutions include a non-inflammatory, biocompatible, and subcutaneous polymeric implant for the controlled release of hydromorphone with zero-order kinetics for treatment of moderate to severe chronic pain. The company offers its hydromorphone implant for treating cancer patients. Axxia Pharmaceuticals, Inc. was incorporated in 1998 and is based in Bel Air, Maryland.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $300.0K
- Funding stage: Seed
- Last round: Seed (Mar 2012)
- Website: axxiapharma.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/axxia-pharmaceuticals-285627 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.